²Î¿¼ÎÄÏ×/References:
[1] ·¶ÅàÅà,Ñî ³¬,Íõ ¸Õ,µÈ.³¬ÉùÒýµ¼ÏÂ΢²¨ÏûÈÚÓë¼××´ÏÙÏÙÒ¶ÇгýÊõÖÎÁƼ××´ÏÙÁ¼ÐÔ½á½ÚµÄЧ¹û¼°Ô¤ºóÓ°ÏìÒòËØ[J].½éÈë·ÅÉäѧÔÓÖ¾,2025,34:385-389.
Fan PP,Yang C,Wang Gg,et al.Ultrasound-guided microwave ablation versus thyroid lobectomy for benign thyroid nodules:comparison of efficacy and analysis of factors influencing prognosis[J].J Intervent Radiol,2025,34:385-389.
[2]Gatta E,Gatta R,Morandi R,et al.Machine Learning for diagnosis of malignant thyroid nodules based on thyroid ultrasound:Systematic review and meta-analysis of studies with external datasets[J].Eur J Radiol Open,2025,16:100716.
[3]Shin D,Ham BJ,Kim KH.Affective morbidity after cancer diagnosis:Nationwide incidence and pharmacotherapy patterns across five major cancer types[J].J Affect Disord,2026,401:121307.
[4]Wang C,Cai Y,Yang X,et al.Plasma proteome mendelian randomization and network pharmacology reveal therapeutic targets for thyroid disorders[J].Mol Cell Endocrinol,2026,615:112752.
[5]ËïÅàÔª,Ò¦Íñæº,¸¶Èðçø,µÈ.2025-2034ÄêÖйúÈËȺ¼××´ÏÙ°©¾¼Ã¸ºµ£Ô¤²â[J].ÖлªÁ÷Ðв¡Ñ§ÔÓÖ¾,2026,47:119-126.
Sun PY,Yao WJ,Fu RY,et al.Prediction of economic burden caused by thyroid cancer in China,2025-2034[J].Chinese Journal of Epidemiology,2026,47:119-126.
[6]Yin J,Wang S,Liu Y.TMED2 promotes thyroid cancer tumorigenesis by being involved in mTORC1-mediated fatty acid metabolism[J].Biochim Biophys Acta Gen Subj,2026,1870:130910.
[7]ÁõÐÄâù,ÕÅ ²¨.³¬ÉùÔÚÀÏÄ껼Õß¼××´ÏÙ°©Õï¶ÏÓëÖÎÁÆÖеÄÓ¦ÓÃÏÖ×´¼°½øÕ¹[J].ÖлªÀÏÄêҽѧÔÓÖ¾,2025,44:561-566.
Liu XY,Zhang B.Application and progress of ultrasound in the diagnosis and treatment of thyroid cancer in elderly patients[J].Chinese Journal of Geriatrics,2025,44:561-566.
[8]Asya O,Yumuÿðþ ‰D akhuylu AC,Enver N,et al.A single-center multidisciplinary study analyzing thyroid nodule risk stratification by comparing the thyroid imaging reporting and data system(TI-RADS)and American thyroid association(ATA)risk of malignancy for thyroid nodules[J].Auris Nasus Larynx,2023,50:410-414.
[9]¸ß Ã÷.¼××´ÏÙ½á½ÚºÍ·Ö»¯Ðͼ××´ÏÙ°©ÕïÖÎÖ¸ÄÏ[J].ÖйúÖ×ÁöÁÙ´²,2012,39:1249-1272.
Gao M.Guidelines for diagnosis and treatment of thyroid nodules and differentiated thyroid cancer[J].Chinese Journal of Clinical Oncology,2012,39:1249-1272.
[10]¹ù»áÇÛ,ÕÔ »À,²Ü ¼ý,µÈ.¼××´ÏÙϸ°û²¡ÀíѧBethesda±¨¸æÏµÍ³µÄÁÙ´²Ó¦ÓÃ:Ö×Áöר¿ÆÒ½Ôº5 729ÀýÑù±¾µÄ»Ø¹ËÐÔ·ÖÎö[J].Öлª¶ú±ÇÑʺíÍ·¾±Íâ¿ÆÔÓÖ¾,2020,55:258-262.
Guo HQ,Zhao Hn,Cao J,et al.Implementation of the Bethesda system for reporting the thyroid cytopathology:study on 5 729 cases from a cancer center[J].Chinese Journal of Otorhinolaryngology Head and Neck Surgery,2020,55:258-262.
[11]Luo P,Ma W,Jia Y,et al.Comparison of two puncture techniques for fine-needle capillary biopsy in thyroid nodules:a randomized controlled trial[J].Endocr J,2026,73:405-416.
[12]Kaltoft M,Sorensen JR,Cramon PK,et al.Improvement in thyroid-specific quality of life after radio frequency ablation of symptomatic benign solitary thyroid nodules:a prospective cohort study[J].Head Neck,2026,48:856-862.
[13]ÁõÖ¾ÑÞ.ÖØÊÓÁÙ´²ÕïÁÆÖ¸ÄÏÔڹ淶»¯¼××´ÏÙ°©²¡Àí±¨¸æÖеÄÖ¸µ¼×÷ÓÃ[J].Öлª²¡ÀíѧÔÓÖ¾,2026,55:3-6.
Liu ZY.The essential role of clinical practice guidelines in standardizing pathological reporting of thyroid carcinoma[J].Chinese Journal of Pathology,2026,55:3-6.
[14]³ÂÀò¾ü,Íõ ÁÕ.Ó°Ïñ×éѧÔÚ¼××´ÏÙ½á½Ú¶¨ÐÔÕï¶ÏÖеÄÑо¿½øÕ¹[J].´Å¹²Õñ³ÉÏñ,2025,16:165-171.
Chen LJ,Wang L.Research progress in radiomics for qualitative diagnosis of thyroid nodules[J].Chinese Journal of Magnetic Resonance Imaging,2025,16:165-171.
[15]Li W,Chang P,Feng M,et al.Pre-ablation stimulated thyroglobulin to TSH ratio as a strong predictor of non-generally satisfactory response to initial radioiodine therapy in papillary thyroid carcinoma patients undergoing lateral neck dissection[J].Ann Med,2026,58:2620341.
[16]Jiang H,Hu B,Xu X,et al.Cellular and molecular determinants of lymph node metastasis in papillary thyroid carcinoma:Integrated multi-omics profiling and machine learning models[J].Comput Biol Chem,2026,121:108857.
[17]»ÆÈð¾ê,´ÔÊçÕä,ÁÖÕñÒâ,µÈ.¶àģ̬³¬Éù³ÉÏñÓÃÓÚTI-RADS 3¡«5Àà¼××´ÏÙ½á½ÚµÄÕï¶Ï¼ÛÖµ[J].Öйú·øÉäÎÀÉú,2024,33:346-352.
Huang RJ,Cong SZ,Lin ZY,et al.Diagnostic value of multimodal ultrasonography for thyroid nodules in thyroid imaging reporting and data system categories 3 to 5[J].Chinese Journal of Radiological Health,2024,33:346-352.
[18]Li L,Deng H,Chen W,et al.Comparison of the diagnostic effectiveness of ultrasound imaging coupled with three mathematical models for discriminating thyroid nodules[J].Acta Radiol,2024,65:441-448.
[19]ÁõÖ¾ÑÞ.¼××´ÏÙϸÕë´©´Ìϸ°ûѧÕï¶ÏÓëÏÝÚå[M].¿ÆÑ§³ö°æÉç,2018.
Liu ZY.Fine needle aspiration cytology diagnosis of thyroid and pitfalls[M].Science Press,2018.
[20]Chen Z,Chambara N,Lo X,et al.Improving the diagnostic strategy for thyroid nodules:a combination of artificial intelligence-based computer-aided diagnosis system and shear wave elastography[J].Endocrine,2025,87:744-757.
[21]Íõ ÄÈ,Íõ ï£,¶ÎÈÎÍñ,µÈ.²ÊÉ«¶àÆÕÀÕ³¬ÉùÁªºÏ³¬ÉùÒýµ¼ÏÂϸÕë´©´Ìϸ°ûѧÔÚ¼××´ÏÙ°©Õï¶ÏÖеÄÓ¦ÓüÛÖµ[J].ʵÓð©Ö¢ÔÓÖ¾,2025,40:1248-1250+1268.
Wang N,Wang Z,Duan RW,et al.Diagnostic value of color doppler ultrasound combined with ultrasound-guided fine needle aspiration cytology in thyroid cancer[J].The Practical Journal of Cancer,2025,40:1248-1250+1268.
[22]ÖÜ çù,Áõ »Ô,Öì³ÉÌÎ,µÈ.ʵʱ¼ôÇв¨µ¯ÐÔ³ÉÏñÒýµ¼Ï¸Õë´©´Ì¼ì²é¶Ô¼××´ÏÙ°©µÄÕï¶Ï¼ÛÖµ[J].ҽѧӰÏñѧÔÓÖ¾,2023,33:144-147.
Zhou Q,Liu H,Zhu CT,et al.Diagnostic value of real-time shear wave elastography guided fine-needle aspiration in thyroid cancer[J].Journal of Medical Imaging,2023,33:144-147.
[23]Verma A,McDowell R,Porreca A.Fine-needle aspiration versus the CytoCore¡k motorized rotating needle device for thyroid nodule biopsies:a retrospective cohort study[J].Acta Cytol,2024,68:405-412.
[24]¹ÈÖ¾Ô¶,²Ì ÚS,³Â»¶»¶,µÈ.SurePath³Á½µÊ½Òº»ùϸ°û²É¼¯¼¼ÊõÓ¦ÓÃÓÚ¼××´ÏÙϸÕë´©´Ìϸ°ûѧÕï¶ÏµÄ׼ȷÐÔÆÀ¼Û[J].ÄϾ©Ò½¿Æ´óѧѧ±¨(×ÔÈ»¿ÆÑ§°æ),2024,44:1550-1557.
Gu ZY,Cai Y,Chen HH,et al.Evaluation of the accuracy of SurePath liquid-based cytology in thyroid fine-needle aspiration[J].Journal of Nanjing Medical University(Natural Sciences),2024,44:1550-1557.
[25]Morse P,Roberts KF,Spies NC,et al.Process improvement in thyroid fine needle aspiration:standardizing number of smears for enhanced adequacy and diagnosis[J].Diagn Cytopathol,2024,52:519-523.
(ÊÕ¸åÈÕÆÚ:2024-10-17)
(±¾Îıà¼:¹È çæ)